| Literature DB >> 34415807 |
Ubenicio Silveira Dias1, Maurício Ruettimann Liberato de Moura1, Publio Cesar Cavalcante Viana1, André Moreira de Assis1, Antônio Sérgio Zanfred Marcelino1, Airton Mota Moreira1, Claudia Costa Leite1, Giovanni Guido Cerri1, Francisco Cesar Carnevale1, Natally Horvat1.
Abstract
Benign prostatic hyperplasia (BPH) is a noncancerous growth of the transitional zone of the prostate, which surrounds the prostatic urethra. Consequently, it can cause lower urinary tract symptoms (LUTS) and bladder outlet obstruction symptoms that may substantially reduce a patient's quality of life. Several treatments are available for BPH, including medications such as α-blockers and 5α-reductase inhibitors and surgical options including transurethral resection of the prostate and prostatectomy. Recently, prostatic artery embolization (PAE) has emerged as a minimally invasive treatment option for selected men with BPH and moderate to severe LUTS. Adequate pre- and postprocedural evaluations with clinical examinations and questionnaires, laboratory tests, and urodynamic and imaging examinations (particularly US, MRI, and CT) are of key importance to achieve successful treatment. Considering that the use of PAE has been increasing in tertiary hospital facilities, radiologists and interventional radiologists should be aware of the main technical concepts of PAE and the key features to address in imaging reports in pre- and postprocedural settings. An invited commentary by Lopera is available online. Online supplemental material is available for this article. ©RSNA, 2021.Entities:
Mesh:
Year: 2021 PMID: 34415807 PMCID: PMC9394104 DOI: 10.1148/rg.2021200144
Source DB: PubMed Journal: Radiographics ISSN: 0271-5333 Impact factor: 6.312